ProColombia Pitches Colombia’s $512 Million USD Digital Health Market to Foreign Investors
New telemedicine rules and 202 startups anchor the investment case
ProColombia and the Ministry of Commerce, Industry and Tourism are promoting Colombia’s digital health sector to international investors, pointing to a domestic market that Statista estimates generated $512 million USD in revenue in 2025, a year in which roughly 1.2 million people used telemedicine services in the country.
The push is framed within Misión Crecer (Growth Mission), the economic strategy of President Abelardo De La Espriella’s government, which targets gross domestic product growth of 6% through higher investment and productivity. The administration markets the broader agenda under the slogan Patria Milagro (Miracle Homeland). The target is a substantial stretch: the National Administrative Department of Statistics reported that the Colombian economy grew 2.6% in 2025.
Mauricio Gómez Amín, the lawyer and former senator from Atlántico who serves as commerce minister in the new cabinet, has tied the investment agenda to regulatory predictability rather than incentives. “Colombia needs clear rules, legal certainty, and a government that sees business owners as an ally, not an adversary,” he said on taking office.
The agency’s pitch rests on three claims that can be checked independently: a regulatory framework that was rewritten this year, a startup base that is real but small, and a technical workforce that graduates in volume.
A rewritten telemedicine rulebook
The Ministry of Health and Social Protection issued Resolución 1644 de 2026 (Resolution 1644 of 2026) on July 31, replacing the 2019 framework that had governed remote care. The ministry’s announcement sets out four telemedicine categories: telexperticia (specialist-to-specialist consultation), teleconcepto (remote clinical opinion), teleconsulta (direct remote consultation), and telemonitoreo (remote monitoring). Each carries its own operating conditions, synchronous or asynchronous communication requirements, and assignment of professional responsibility.
The resolution draws a line between telehealth activities that do not require licensing and telemedicine services that do. Orientation, clinical support, and education delivered remotely fall outside the licensing regime; telemedicine proper must be registered in the national provider registry. Prescribing is permitted only under telexperticia, teleconsulta, and teleconcepto, using electronic, digital, or digitized signatures.
Two provisions matter for anyone modeling revenue. Health insurers may not deny coverage or refuse payment for services delivered remotely when those services are already covered, which removes a reimbursement risk that had constrained earlier deployments. And the rules create a punto de enlace en telemedicina (telemedicine link point), a facility type aimed at rural and hard-to-reach communities that does not require full licensing but must meet minimum infrastructure and connectivity standards.
The resolution also addresses artificial intelligence directly, permitting its use as technological support under human supervision while stating that it cannot replace clinical judgment, professional autonomy, or the doctor-patient relationship. Providers already delivering telemedicine have twelve months to comply. Differential conditions apply to municipalities of 20,000 or fewer inhabitants, conflict-affected territories, and areas with significant ethnic populations.
On the infrastructure side, the health ministry reports that more than 2,400 public and private facilities now operate on the national interoperability mechanism for electronic medical records, through which more than 7.7 million clinical records have been exchanged.
A startup base that is real but thinly capitalized
The Colombia Tech Report 2025-2026, produced by KPMG and partner organizations, identified 202 startups in its Healthtech, Wellness and Life Sciences category, equivalent to 9% of the technology companies covered. That places the category third by company count, spanning telemedicine platforms, hospital software, connected devices, remote monitoring, and clinical applications of artificial intelligence.
The funding picture is narrower than the company count suggests. The report recorded $11 million USD of venture capital investment across seven healthtech transactions during 2025, with 95% of the capital raised by the segment concentrated in three companies. Against the report’s national totals of 2,295 active startups and $857 million USD raised across 131 transactions, healthtech accounted for well under 2% of the capital deployed in Colombian technology last year.
Geographic concentration compounds the point. The same report places roughly half of Colombia’s startups in Bogotá, which captured 89% of all capital invested, while Medellín holds about a quarter of the companies and received 6.2% of funding. Eight in ten Colombian startups remain at early stages, and only 17% are actively raising venture capital.

A physician researcher and a developer review epidemiological and remote care data on an interactive display. (Photo courtesy ProColombia)
Talent supply and the international market
According to the Ministry of National Education, Colombia produced 134,138 graduates in science, technology, engineering, and mathematics in 2025, including 46,097 in software and information technology programs. ProColombia presents that base as capable of supporting specialized software development, data analysis, applied artificial intelligence, and research work, alongside hospital management, diagnostic, and patient-monitoring products built for export.
The international backdrop is the other half of the pitch. Mordor Intelligence projects the global digital health market will expand from $405.99 billion USD in 2026 to $884.43 billion USD in 2031, a compound annual growth rate of 16.85%. Colombia’s $512 million USD market represents roughly one-tenth of one percent of that 2026 global figure.
What the promotion does and does not settle
For investors weighing Colombian healthtech, the 2026 resolution resolves questions that had been genuine obstacles: whether remote care could be billed reliably, under what licensing burden a rural access point operates, and where artificial intelligence sits in the liability chain. Those are the conditions under which a telemedicine business can be underwritten rather than piloted.
What the promotion does not resolve is the capital gap. A sector with 202 companies and $11 million USD in annual venture funding, nearly all of it going to three firms, is a sector where most participants are not yet financeable at scale. ProColombia’s case is that the regulatory groundwork now precedes the capital rather than trailing it. Whether foreign investors agree will show up in the 2026 transaction count rather than in the promotional materials.
Colombia’s investment promotion agency has been active in technology and services recruitment, having announced more than $1 billion USD in new foreign direct investment and traveled to California with Invest Pacific to promote technology and services investment in the southwest of the country.
Headline photo: A physician reviews remote patient monitoring data during a telemedicine consultation. (Photo courtesy ProColombia)

































